Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson’s Disease: A 5-Year Follow-Up Study julio 19, 2024octubre 7, 2024
Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study marzo 12, 2022enero 6, 2023
How can I assess my patients with Parkinson’s disease during a busy clinic day? agosto 18, 2020agosto 18, 2023
Depressive Symptoms and Their Impact on Quality of Life in Parkinson’s Disease: An Exploratory Network Analysis Approach julio 18, 2020agosto 18, 2023
COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression febrero 25, 2016octubre 7, 2022
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson’s Disease: A 5-Year Follow-Up Study julio 23, 2004octubre 7, 2024
Staging Parkinson’s disease according to the MNCD classification correlates with caregiver burden mayo 15, 2004mayo 15, 2024
Response to levodopa in Parkinson’s disease over time. A 4-year follow-up study octubre 5, 2003mayo 15, 2024
Effects of brain asymmetry on clinical manifestations and quality of life in Parkinson´s disease octubre 25, 1920octubre 25, 2022
